Randomized, Double-blind, Parallel Trial Comparing the Effects of Eltoprazine (Adjunct to Anti-psychotics) With Placebo in Adults With Schizophrenia, in Improving One or More Dimensions of Cognitive Impairment Associated With Schizophrenia.
Phase of Trial: Phase II
Latest Information Update: 16 Apr 2015
At a glance
- Drugs Eltoprazine (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- 13 Apr 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov
- 02 May 2012 Planned end date changed from 1 Jun 2012 to 1 Nov 2012 as reported by ClinicalTrials.gov.
- 17 Aug 2011 Planned end date changed from 1 Mar 2012 to 1 Jun 2012 as reported by ClinicalTrials.gov.